<p><b>A</b>, Radio-sensitivity assay of cells treated with EGFR and IGF1R inhibitors. Cancer cells of different groups were treated without (control) or with AG1024 (10 µM), Erlotinib (10 µM) or both for 1 h and then subjected to radio-sensitivity clonogenic assay. After 10 days, the clones were fixed and stained. Surviving fraction was calculated according to the colony counts and plating efficiency. <b>B</b>, Radio-sensitivity assay of cells treated with EGFR and IGF1R siRNAs. Cells of different groups were transfected with non-silencing control siRNA (NSC-siRNA), EGFR and/or IGF1R siRNA, and then subjected to radio-sensitivity clonogenic assay as described in panel A. <b>C</b>, Apoptosis of cells treated with EGFR and IGF1R inhibitors. P...
BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors are in clinical development in cancer...
BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors are in clinical development in cancer...
BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors are in clinical development in cancer...
<div><p>Reduced sensitivity of prostate cancer (PC) cells to radiation therapy poses a significant c...
Reduced sensitivity of prostate cancer (PC) cells to radiation therapy poses a significant challenge...
Reduced sensitivity of prostate cancer (PC) cells to radiation therapy poses a significant challenge...
<p><b>A</b>, Immunoprecipitation detecting EGFR/IGF1R interaction. DU145 and PC3 cells were irradiat...
Purpose: To determine the direct effects of the epidermal growth factor receptor (EGFR) inhibitor C2...
<p><b>A</b>, Dose-proliferation relation of nude mouse xenograft growth. Prostate cancer DU145 and i...
Epidermal growth factor receptor (EGFR), a receptor often expressed in nasopharyngeal carcinoma (NPC...
The Epidermal Growth Factor Receptor (EGFR) and its mutations contribute in various ways to tumorige...
<p>Lung cancer cell lines were treated with EGFR-specific-siRNA 1247. Live cells and apoptotic cells...
BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors are in clinical development in cancer...
<div><p>The Epidermal Growth Factor Receptor (EGFR) and its mutations contribute in various ways to ...
BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors are in clinical development in cancer...
BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors are in clinical development in cancer...
BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors are in clinical development in cancer...
BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors are in clinical development in cancer...
<div><p>Reduced sensitivity of prostate cancer (PC) cells to radiation therapy poses a significant c...
Reduced sensitivity of prostate cancer (PC) cells to radiation therapy poses a significant challenge...
Reduced sensitivity of prostate cancer (PC) cells to radiation therapy poses a significant challenge...
<p><b>A</b>, Immunoprecipitation detecting EGFR/IGF1R interaction. DU145 and PC3 cells were irradiat...
Purpose: To determine the direct effects of the epidermal growth factor receptor (EGFR) inhibitor C2...
<p><b>A</b>, Dose-proliferation relation of nude mouse xenograft growth. Prostate cancer DU145 and i...
Epidermal growth factor receptor (EGFR), a receptor often expressed in nasopharyngeal carcinoma (NPC...
The Epidermal Growth Factor Receptor (EGFR) and its mutations contribute in various ways to tumorige...
<p>Lung cancer cell lines were treated with EGFR-specific-siRNA 1247. Live cells and apoptotic cells...
BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors are in clinical development in cancer...
<div><p>The Epidermal Growth Factor Receptor (EGFR) and its mutations contribute in various ways to ...
BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors are in clinical development in cancer...
BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors are in clinical development in cancer...
BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors are in clinical development in cancer...
BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors are in clinical development in cancer...